Literature DB >> 11389695

Transcriptional activities of p73 splicing variants are regulated by inter-variant association.

Y Ueda1, M Hijikata, S Takagi, T Chiba, K Shimotohno.   

Abstract

p73 has been identified as a gene that encodes a protein with significant identity with the tumour suppressor p53. The main structural difference between p73 and p53 is the additional C-terminal region of p73. Six isoforms of p73 with differing C-terminal structures, alpha, beta, gamma, delta, epsilon and xi, have been reported. These variants differ in transcriptional activity on p53-responsive promoters. Here we report a possible mechanism of transcriptional activation by p73 splicing variants. C-terminal deletion mutants of p73 alpha showed a significantly higher level of transcriptional activity than wild-type p73 alpha, suggesting that the C-terminal structure of p73 alpha functions to repress the transcriptional activity of p73 alpha. The results of immunoprecipitation assays and two-hybrid assays in mammalian cells showed that the p73 variants interacted with each other, but not with p53. The transcriptional activity of p73 beta was reduced by co-expression with either p73 alpha or p73 epsilon, which bears an identical C-terminal structure to p73 alpha. Co-expression of the C-terminal portion of p73 alpha or p73 epsilon with p73 beta also resulted in reduced transcriptional activity. Moreover, we observed that the level of endogenous p21 protein induced by p73 beta was decreased by co-expression of full-length p73 epsilon or the C-terminal region of p73 alpha or p73 epsilon. These observations suggest that p73-mediated gene expression is regulated by the interactions of p73 splicing variants in the cell.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11389695      PMCID: PMC1221914          DOI: 10.1042/0264-6021:3560859

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  29 in total

1.  New p73 variants with altered C-terminal structures have varied transcriptional activities.

Authors:  Y Ueda; M Hijikata; S Takagi; T Chiba; K Shimotohno
Journal:  Oncogene       Date:  1999-09-02       Impact factor: 9.867

2.  p53 functions as a cell cycle control protein in osteosarcomas.

Authors:  L Diller; J Kassel; C E Nelson; M A Gryka; G Litwak; M Gebhardt; B Bressac; M Ozturk; S J Baker; B Vogelstein
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

3.  p73 is up-regulated in a subset of hepatocellular carcinomas.

Authors:  N I Herath; M C Kew; V L Whitehall; M D Walsh; J R Jass; K K Khanna; J Young; L W Powell; B A Leggett; G A Macdonald
Journal:  Hepatology       Date:  2000-03       Impact factor: 17.425

Review 4.  p53: puzzle and paradigm.

Authors:  L J Ko; C Prives
Journal:  Genes Dev       Date:  1996-05-01       Impact factor: 11.361

5.  Inhibition of p53-mediated transactivation by E6 of type 1, but not type 5, 8, or 47, human papillomavirus of cutaneous origin.

Authors:  T Kiyono; A Hiraiwa; S Ishii; T Takahashi; M Ishibashi
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

6.  p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours.

Authors:  A Yang; N Walker; R Bronson; M Kaghad; M Oosterwegel; J Bonnin; C Vagner; H Bonnet; P Dikkes; A Sharpe; F McKeon; D Caput
Journal:  Nature       Date:  2000-03-02       Impact factor: 49.962

7.  Differential expression of p73 splice variants and protein in benign and malignant ovarian tumours.

Authors:  D Zwahlen; M P Tschan; T J Grob; U R Peters; D Fink; W Haenggi; H J Altermatt; J F Cajot; A Tobler; M F Fey; S Aebi
Journal:  Int J Cancer       Date:  2000-10-01       Impact factor: 7.396

8.  Deletion of the COOH-terminal region of p73alpha enhances both its transactivation function and DNA-binding activity but inhibits induction of apoptosis in mammalian cells.

Authors:  T Ozaki; M Naka; N Takada; M Tada; S Sakiyama; A Nakagawara
Journal:  Cancer Res       Date:  1999-12-01       Impact factor: 12.701

9.  Role for the p53 homologue p73 in E2F-1-induced apoptosis.

Authors:  M Irwin; M C Marin; A C Phillips; R S Seelan; D I Smith; W Liu; E R Flores; K Y Tsai; T Jacks; K H Vousden; W G Kaelin
Journal:  Nature       Date:  2000-10-05       Impact factor: 49.962

10.  Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus.

Authors:  M Hijikata; H Mizushima; T Akagi; S Mori; N Kakiuchi; N Kato; T Tanaka; K Kimura; K Shimotohno
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

View more
  10 in total

1.  TAp73alpha protects small cell lung carcinoma cells from caspase-2 induced mitochondrial mediated apoptotic cell death.

Authors:  Naveen Muppani; Ulrika Nyman; Bertrand Joseph
Journal:  Oncotarget       Date:  2011-12

Review 2.  Transcriptional deregulation underlying the pathogenesis of small cell lung cancer.

Authors:  Dong-Wook Kim; Keun-Cheol Kim; Kee-Beom Kim; Colin T Dunn; Kwon-Sik Park
Journal:  Transl Lung Cancer Res       Date:  2018-02

3.  Direct activation of forkhead box O3 by tumor suppressors p53 and p73 is disrupted during liver regeneration in mice.

Authors:  Svitlana Kurinna; Sabrina A Stratton; Wen-Wei Tsai; Kadir C Akdemir; Weisong Gu; Pallavi Singh; Triona Goode; Gretchen J Darlington; Michelle Craig Barton
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

4.  BUB3 that dissociates from BUB1 activates caspase-independent mitotic death (CIMD).

Authors:  Y Niikura; H Ogi; K Kikuchi; K Kitagawa
Journal:  Cell Death Differ       Date:  2010-01-08       Impact factor: 15.828

Review 5.  Regulation of p73 activity by post-translational modifications.

Authors:  F Conforti; A E Sayan; R Sreekumar; B S Sayan
Journal:  Cell Death Dis       Date:  2012-03-15       Impact factor: 8.469

6.  Hsp72 mediates TAp73α anti-apoptotic effects in small cell lung carcinoma cells.

Authors:  Ulrika Nyman; Naveen Reddy Muppani; Boris Zhivotovsky; Bertrand Joseph
Journal:  J Cell Mol Med       Date:  2011-08       Impact factor: 5.310

7.  p73 coordinates with Δ133p53 to promote DNA double-strand break repair.

Authors:  Hongjian Gong; Yuxi Zhang; Kunpeng Jiang; Shengfan Ye; Shuming Chen; Qinghe Zhang; Jinrong Peng; Jun Chen
Journal:  Cell Death Differ       Date:  2018-03-06       Impact factor: 15.828

8.  The BAG-1 cochaperone is a negative regulator of p73-dependent transcription.

Authors:  X-H Wang; D O'Connor; M Brimmell; G Packham
Journal:  Br J Cancer       Date:  2009-03-17       Impact factor: 7.640

9.  C-terminal diversity within the p53 family accounts for differences in DNA binding and transcriptional activity.

Authors:  Markus Sauer; Anne Catherine Bretz; Rasa Beinoraviciute-Kellner; Michaela Beitzinger; Christof Burek; Andreas Rosenwald; Gregory S Harms; Thorsten Stiewe
Journal:  Nucleic Acids Res       Date:  2008-02-11       Impact factor: 16.971

10.  The cell type-specific effect of TAp73 isoforms on the cell cycle and apoptosis.

Authors:  Jitka Holcakova; Pavla Ceskova; Roman Hrstka; Petr Muller; Lenka Dubska; Philip J Coates; Emil Palecek; Borivoj Vojtesek
Journal:  Cell Mol Biol Lett       Date:  2008-03-18       Impact factor: 5.787

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.